These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31136999)

  • 1. CROI 2019: advances in HIV prevention and plans to end the epidemic.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2019 Apr; 27(1):8-25. PubMed ID: 31136999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CROI 2017: HIV Epidemic Trends and Advances in Prevention.
    Liu AY; Buchbinder SP
    Top Antivir Med; 2017; 25(2):35-50. PubMed ID: 28598789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CROI 2014: New tools to track the epidemic and prevent HIV infections.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2014 May; 22(2):579-93. PubMed ID: 24901884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
    Landovitz RJ
    Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.
    Liu AY; Buchbinder SP
    Top Antivir Med; 2024 Jul; 32(3):447-482. PubMed ID: 39142289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CROI 2018: Epidemic Trends and Advances in HIV Prevention.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2018 May; 26(1):1-16. PubMed ID: 29727292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM; Mellors JW
    Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis.
    Rozhnova G; Heijne J; Bezemer D; van Sighem A; Presanis A; De Angelis D; Kretzschmar M
    AIDS; 2018 Nov; 32(17):2615-2623. PubMed ID: 30379687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CROI 2015: Advances in HIV Testing and Prevention Strategies.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2015; 23(1):8-27. PubMed ID: 25965309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Evans C; Hoverman A; Sun C; Dana T; Bougatsos C; Grusing S; Korthuis PT
    JAMA; 2019 Jun; 321(22):2214-2230. PubMed ID: 31184746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    Durand-Zaleski I; Mutuon P; Charreau I; Tremblay C; Rojas D; Pialoux G; Chidiac C; Capitant C; Spire B; Cotte L; Chas J; Meyer L; Molina JM;
    AIDS; 2018 Jan; 32(1):95-102. PubMed ID: 29210777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2016; 24(1):10-28. PubMed ID: 27398859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
    PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans.
    Spinner CD; Boesecke C; Zink A; Jessen H; Stellbrink HJ; Rockstroh JK; Esser S
    Infection; 2016 Apr; 44(2):151-8. PubMed ID: 26471511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.